• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

RCT Results: Can the Use of “Mindfetalness” to Assess Fetal Movements Decrease Adverse Pregnancy Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • There is a long history of using kick counts to monitor fetal wellbeing but data is conflicting as to whether there is benefit vs harm from generating undue concern
  • ‘Mindfetalness’ encourages women to lie on their side for 15 min each day while the fetus is awake and monitor the overall character of the movement, but not to count each kick
  • Akselsson et al. (BJOG, 2020) assessed whether using Mindfetalness could affect pregnancy outcomes

METHODS:

  • Cluster-randomized controlled trial
  • Setting
    • 67 maternity clinics in Sweden
  • Participants
    • Singleton pregnancy
    • >32 weeks’ gestation
  • Intervention
    • Guidance on using Mindfetalness
    • Standard care
  • Study design
    • If randomized to Mindfetalness, patient received a leaflet about Mindfetalness at 24 weeks | Structured observation began at 28 weeks
    • Data collected from a population-based registry
  • Mindfetalness instructions
    • Lie down on side for 15 minutes per day when baby was awake
    • Monitor the character, strength, and frequency of the fetal movements
    • Do not count each movement
    • Use/trust intuition and to seek care if worried about fetal wellbeing
  • Primary outcomes
    • Apgar score <7 at 5 minutes after birth
    • Healthcare contact due to decrease in fetal movements
  • Secondary outcomes
    • Apgar score <4 at 5 minutes
    • SGA
    • Mode of delivery

RESULTS:

  • 39,865 women included
    • Mindfetalness: 19, 639
    • Standard care: 20,226
  • There was no difference in 5-minute Apgar score <7 for infants
    • Mindfetalness: 1.1%
    • Standard care: 1.1%
    • Relative risk (RR) 1.0 (95% CI, 0.8 to 1.2)
  • Women in the Mindfetalness group contacted a healthcare professional more often due to decreased fetal movements
    • Mindfetalness: 6.6%
    • Standard care: 3.8%
    • RR 1.72 (95% CI, 1.57 to 1.87)
  • Mindfetalness was associated with a reduction in the number of
    • Infants born SGA
      • RR 0.95 (95% CI, 0.90 to 1.00)
    • Infants born >41w6d
      • RR 0.91 (95% CI, 0.83 to 0.98)
    • Cesarean birth
      • Mindfetalness: 19.0%
      • Standard care: 20.0%
      • RR 0.95 (95% CI, 0.91 to 0.99)

CONCLUSION:

  • The use of Mindfetalness during pregnancy was not associated with a reduction in the number of infants born with an Apgar score <7
  • However, the use of Mindfetalness was associated with a decrease in the number of cesarean birth and infants born SGA
  • The authors acknowledge limitations to the study, including the fact that some women in the Mindfetalness group may not have received their leaflet or chose not to follow the instructions on the leaflet | However, this reflects a pragmatic ‘real world’ study

Learn More – Primary Sources:

Mindfetalness to increase women’s awareness of fetal movements and pregnancy outcomes: a cluster-randomised controlled trial including 39 865 women

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Does Fetal Movement Counting Reduce Risk of Stillbirth?
How Well Can Perceived Changes in Fetal Movements Predict Stillbirth?
The AFFIRM Trial: Does Maternal Awareness of Fetal Movement Counts Reduce Stillbirth Risk

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site